Land: Nieuw-Zeeland
Taal: Engels
Bron: Medsafe (Medicines Safety Authority)
Etoposide 100mg
Link Pharmaceuticals Ltd
Etoposide 100 mg
100 mg
Capsule
Active: Etoposide 100mg Excipient: Citric acid monohydrate Gelatin Glycerol Iron oxide red Macrogol 400 Propyl hydroxybenzoate Sodium ethyl hydroxybenzoate Titanium dioxide Water
Blister pack, 10 capsules
Prescription
Prescription
Nippon Kayaku Co Ltd
Package - Contents - Shelf Life: Blister pack, - 10 capsules - 36 months from date of manufacture stored at or below 25°C
1982-10-21
VEPESID® CMI May 2022 1 VEPESID® CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I USING VEPESID? VEPESID contains the active ingredient etoposide. VEPESID is used to treat certain types of lung cancer, leukaemia (blood cancer),lymphoma (cancer of the lymph glands), and testicular tumours. For more information, see Section 1. Why am I using VEPESID? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I USE VEPESID? Do not use if you have ever had an allergic reaction to etoposide or any of the ingredients listed at the end of the CMI. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING. For more information, see Section 2. What should I know before I use VEPESID? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with VEPESID and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I USE VEPESID? • VEPESID capsules may be given to you at the hospital or surgery, or you may take them yourself at home • You should take VEPESID capsules on an empty stomach • VEPESID is usually given each day for between 3 and 5 days. This is followed by a treatment-free interval of 2-4 weeks More instructions can be found in Section 4. How do I use VEPESID? in the full CMI. 5. WHAT SHOULD I KNOW WHILE USING VEPESID? THINGS YOU SHOULD DO • Be sure to keep all your doctor's appointments so your progress can be checked • Remind any doctor, dentist, nurse or pharmacist you visit that you are using VEPESID THINGS YOU SHOULD NOT DO • Do not stop using this medicine or change the dosage without checking with your doctor DRIVING OR USING MACHINES • VEPESID may cause dizziness, light-headedness, tiredness, changes in vision or vomiting in some people. If this occurs do not drive. • Be caref Lees het volledige document
Vepesid v9.0 1 DATA SHEET 1 PRODUCT NAME VEPESID ® 50 mg and 100 mg capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Pale pink, soft gelatin capsules containing 50 mg or 100 mg etoposide. Excipients with known effect: Each 50 mg capsule contains 0.47 mg of parahydroxybenzoate. Each 100 mg capsule contains 0.61 mg of parahydroxybenzoate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Soft gelatin capsule. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS VEPESID is indicated in the treatment of: SMALL CELL LUNG CANCER - VEPESID Capsules in combination with other approved chemotherapeutic agents as first-line treatment in patients with small cell lung cancer. HODGKIN'S DISEASE. MALIGNANT (NON-HODGKIN'S) LYMPHOMAS, ESPECIALLY OF THE HISTIOCYTIC VARIETY. ACUTE NON-LYMPHOCYTIC LEUKAEMIA. TESTICULAR TUMOURS in combination regimens for the treatment of refractory testicular tumours 4.2 DOSE AND METHOD OF ADMINISTRATION VEPESID should only be administered and monitored under the supervision of a qualified physician experienced in the use of anti-neoplastic medicinal products. The dose of VEPESID capsules is based on the recommended dose with consideration given to the bioavailability of VEPESID capsules appearing to be dependent upon the dose administered. In view of significant intra-patient variability, dose adjustment may be required to achieve the desired therapeutic effect. The usual dose of VEPESID capsules is 100-200 mg/m 2 (body surface area)/day, days 1 to 5 or 200 mg/m 2 /day, days 1, 3 and 5 every 3 to 4 weeks in combination with other agents approved for use in the disease to be treated. Dosage should be modified to take into account the myelosuppressive effects of other medications in the combination or the effects of prior X-ray therapy or chemotherapy which may have compromised bone marrow reserve. Capsules should be taken on an empty stomach. ELDERLY: No dosage adjustment is necessary; however, total dosage per course should not exceed Vepesid v9.0 2 650 mg/m 2 . The usual nu Lees het volledige document